Latest / Stuff They Don't Want You To Know / CLASSIC: Who created the opioid epidemic?
Transcript
- 0:00Speaker 1: Welcome to tonight's classic episode fellow conspiracy realist, the Sackler Family.
- 0:05Speaker 2: They did it? Wait wait, the Usher.
- 0:09Speaker 3: Family exactly shout out to follow the House of Usher.
- 0:13Speaker 3: I think, honestly, of all of the opioid epidemic kind
- 0:17Speaker 3: of dramatizations, it gets it the best.
- 0:22Speaker 4: You watched it, finally, Matt, I've watching it. I think
- 0:24Speaker 4: it's it kicks ass.
- 0:26Speaker 2: It's so good.
- 0:26Speaker 4: But obviously a really serious topic.
- 0:29Speaker 3: We know that some of the pieces have fallen in
- 0:32Speaker 3: the game of chess, that is the US government's prosecution
- 0:35Speaker 3: of the Sackler family. Of course, the top, top, top
- 0:39Speaker 3: members of that family have largely gone, you know, with
- 0:41Speaker 3: its laps on wrists, and that's just unfortunately how these
- 0:44Speaker 3: kinds of things go.
- 0:45Speaker 2: But is it just them that's right now?
- 0:47Speaker 3: Of course, Yeah, there's a lot of nuance to this
- 0:49Speaker 3: conversation and a lot of players and moving pieces in
- 0:53Speaker 3: what actually created the opioid epidemic? Was it manufactured?
- 0:58Speaker 2: You know?
- 0:58Speaker 4: Was it a conspiracy from the highest levels?
- 1:02Speaker 1: And now in twenty twenty three, we can once again
- 1:05Speaker 1: look back at this and remember the old adage, if
- 1:09Speaker 1: the punishment for a crime is a fine, then the
- 1:12Speaker 1: ultimate crime is just being poor. From UFOs to psychic
- 1:17Speaker 1: powers and government conspiracies, history is riddled with unexplained events.
- 1:22Speaker 1: You can turn back now or learn the stuff they
- 1:25Speaker 1: don't want you to know.
- 1:39Speaker 2: Welcome back to the show. My name is Max, my.
- 1:42Speaker 4: Name is Noel.
- 1:43Speaker 1: They call me Ben. We are joined with our super
- 1:45Speaker 1: producer Paul Deckett. Most importantly, you are here. You are you,
- 1:49Speaker 1: and that makes this stuff they don't want you to know.
- 1:53Speaker 1: Today's episode deals with some issues that people may find
- 1:58Speaker 1: personally very disturbing. But we are here to shed a
- 2:03Speaker 1: little bit of daylight into a murky world and a
- 2:09Speaker 1: catastrophic occurrence that the US and other countries are experiencing
- 2:14Speaker 1: as we record the episode today, the subjects conspiracy Realist
- 2:20Speaker 1: is drugs, drug use, drug abuse, manufacturing and manufacturing. Oh
- 2:26Speaker 1: that's the most important part. Yes, whether we are talking
- 2:29Speaker 1: legal drugs, illegal, recreational, or purely medicinal, it's no secret.
- 2:34Speaker 1: There's a huge business, a multi billion dollar business. And
- 2:38Speaker 1: each day across this planet of ours, millions of people
- 2:41Speaker 1: depend on some form of drug to either what prolonged
- 2:45Speaker 1: their lives, to combat an ongoing incurable disease or condition,
- 2:49Speaker 1: or to escape their problems, whatever those may be. In
- 2:52Speaker 1: many cases, consumption of recreational drugs leads to injury or death.
- 2:58Speaker 1: And depending on where you're from, this is a question
- 3:00Speaker 1: for everyone. You may have grown up in a school
- 3:03Speaker 1: system with an anti drug program. I think we the
- 3:07Speaker 1: three of us, mentioned it before on the show Dare
- 3:09Speaker 1: Here in the United States.
- 3:11Speaker 4: Yeah, yeah, yeah, they ought to call it scare because
- 3:13Speaker 4: I have this really distinct memory of being in elementary
- 3:16Speaker 4: school and somebody giving this speech about when they were
- 3:19Speaker 4: addicted to crack cocaine and talking about like, and I
- 3:23Speaker 4: looked in the mirror one day and what I saw
- 3:26Speaker 4: was a skeleton looking back at me. And in my
- 3:28Speaker 4: third grade mind or whatever grade mind, I thought he
- 3:31Speaker 4: meant really like he saw a spooky skeleton looking back
- 3:35Speaker 4: at him in the mirror, and I was like, drugs
- 3:37Speaker 4: are terrifying.
- 3:38Speaker 2: Yeah. Yeah, the old drug abuse resistance education program it was.
- 3:43Speaker 2: It was rampant in my school. Dare to say No.
- 3:47Speaker 1: Yes, Dare to keep a kid off drugs, Dare to
- 3:50Speaker 1: give a kid some hope. These are lyrics from the
- 3:52Speaker 1: song They Make You See.
- 3:54Speaker 4: Now it's just been relegated to a trendy hipster thrift
- 3:57Speaker 4: store shirt. Yeah, you get your hands on one of those,
- 4:00Speaker 4: you're living large.
- 4:01Speaker 1: Yeah, Yeah, I think it's it's great to have them.
- 4:03Speaker 1: I still have some of my old Dear shirts, and.
- 4:05Speaker 2: I would say I, I I'm not against this idea
- 4:10Speaker 2: of having drug abuse resistant programs within schools. But there's
- 4:15Speaker 2: there's more to that story, but we can get into
- 4:17Speaker 2: that later.
- 4:18Speaker 1: Yeah, I'm not against it either in theory. It's I'm
- 4:21Speaker 1: torn because I think in many cases some of those
- 4:26Speaker 1: programs encouraged kids to experiment with drugs.
- 4:29Speaker 4: Well, they did it throughout my education high school, high
- 4:33Speaker 4: school too, And I remember in high school somebody came
- 4:35Speaker 4: in with this like suitcase with replicas of all the drugs,
- 4:39Speaker 4: and I was like, I want to try that. I
- 4:41Speaker 4: want to try that. I want to try not really,
- 4:43Speaker 4: but it's it just it has this like candy vibe
- 4:46Speaker 4: to it, where everything looks like a fun little thing
- 4:48Speaker 4: you want to check out.
- 4:49Speaker 1: It's a little weird, and their success remains a matter
- 4:53Speaker 1: of debate today. These sorts of programs. You know, how
- 4:57Speaker 1: many of those how many of those kids in high
- 4:59Speaker 1: schoo would Okay, The joke at a school I attended
- 5:06Speaker 1: briefly was that you could tell all the kids who
- 5:09Speaker 1: won the essay awards for Dare because they were the
- 5:12Speaker 1: biggest potheads by senior year. Wow, every single one. And
- 5:17Speaker 1: maybe that's just that school, right. But today we're talking
- 5:21Speaker 1: about a certain type of drug, one that you may
- 5:24Speaker 1: have seen in that suitcase that Noel had just mentioned
- 5:27Speaker 1: when you were a child, One that previously launched numerous wars,
- 5:31Speaker 1: one that has shaped a lot of human civilization and
- 5:35Speaker 1: experienced the sinister renaissance in the modern age. Today we're
- 5:39Speaker 1: talking about opium, specifically the opioid crisis. So here are
- 5:45Speaker 1: the facts. First, what is opium? What is opium? What
- 5:49Speaker 1: is an opioid? How they how do they measure up?
- 5:52Speaker 2: Right? Opium is this old substance that's been around for forever.
- 5:57Speaker 2: It's a bitter, brownish, addictive narcotic drug. It consists of
- 6:01Speaker 2: the dried latex that surrounds immature seed capsules in this
- 6:07Speaker 2: this happy little flower plant called an opium poppy.
- 6:10Speaker 4: It's interesting to me because a lot of marijuana legalization advocates.
- 6:14Speaker 4: One of their arguments is, well, it grows from the ground,
- 6:16Speaker 4: so it's got to be okay. Well, you know, so
- 6:19Speaker 4: do poppies, and so do the coca plants, so kind
- 6:22Speaker 4: of it kind of kills that argument dead.
- 6:24Speaker 1: Yeah, that's a good point. And also, of course hashtag
- 6:27Speaker 1: not all poppies. The plant is that there's a specific
- 6:33Speaker 1: type of poppy, the opium poppy, that is used to
- 6:37Speaker 1: create this substance, and it.
- 6:39Speaker 2: Has been cultivated over millennia.
- 6:42Speaker 4: Yeah.
- 6:42Speaker 1: Yeah, yeah, it dates way back and people loved it
- 6:47Speaker 1: when they first discovered it because it produces a lower
- 6:50Speaker 1: state of anxiety an increased sense of well being. You
- 6:54Speaker 1: get drowsy, you get a little apathetic, it's tough to concentrate,
- 6:58Speaker 1: and there are physical effects that you will hear people
- 7:01Speaker 1: relay as ways to encounter, ways to tell physically if
- 7:06Speaker 1: someone is under the influence of opium or an opioid.
- 7:08Speaker 1: Like a lat of law enforcement spends time teaching their
- 7:12Speaker 1: officials to diagnose on the fly, which is relatively unscientific.
- 7:17Speaker 4: I think it causes constriction of the pupils. For example,
- 7:21Speaker 4: they get very tiny.
- 7:23Speaker 2: Yeah, and there's also a euphoria associated with it when
- 7:27Speaker 2: taken at certain levels with doses.
- 7:29Speaker 1: Yeah, that's why people chase the dragon, right, So they've
- 7:33Speaker 1: been chasing this dragon or people who use opium and
- 7:36Speaker 1: been chasing it for more than five thousand years. The
- 7:39Speaker 1: first references to growth and use date back to three thousand,
- 7:43Speaker 1: four hundred BCE, when Mesopotamians cultivated the opium poppy. Mesopotamia
- 7:50Speaker 1: is more or less where we would picture Southwest Asia today,
- 7:56Speaker 1: and Samerians referred to it as whole gill the way plant,
- 8:00Speaker 1: which makes sense.
- 8:01Speaker 2: Yeah.
- 8:03Speaker 1: They passed it on to the Assyrians. The Assyrians passed
- 8:05Speaker 1: it on to the Egyptians. Greco Romans, of course, were
- 8:09Speaker 1: in the game. They also they saw it as a
- 8:12Speaker 1: both a painkiller and a something to do with bowels.
- 8:16Speaker 1: I can't remember if it was supposed to stop you
- 8:19Speaker 1: up or let you go.
- 8:20Speaker 4: I think it stops you up. I think that side
- 8:22Speaker 4: effect of opiate addiction is a chronic constipation.
- 8:26Speaker 1: So they understood its medicinal use in that regard.
- 8:29Speaker 4: But of course, would you want to do that if
- 8:32Speaker 4: you had like diarrhea, you had some kind of.
- 8:37Speaker 2: You die from diarrhea.
- 8:40Speaker 1: Yeah, But regardless though, the the primary appeal of this
- 8:46Speaker 1: substance had has always been the way it makes you feel, right,
- 8:51Speaker 1: uh pooper non poop aside, and the demand for this
- 8:55Speaker 1: increased internationally in early international trade opium play an increasingly
- 9:01Speaker 1: significant role. It it's easy to grow, so people in
- 9:06Speaker 1: the right climate would say, why do I have to
- 9:08Speaker 1: buy this stuff from this shady you know, the shady
- 9:12Speaker 1: Roman or the shady Assyrian or whatever, when I can
- 9:16Speaker 1: just take a poppy and then grow my own and
- 9:18Speaker 1: maybe you know, take care of my supply and then
- 9:21Speaker 1: sell it. So other countries began to grow this industry
- 9:24Speaker 1: and they expanded its availability. The old rule of supply
- 9:29Speaker 1: and demand still played a role here, so opium got
- 9:32Speaker 1: cheaper too as more countries were growing it.
- 9:35Speaker 2: And it quickly becomes a cash crop for a lot
- 9:37Speaker 2: of places.
- 9:38Speaker 4: Yes, as it remains so today, places that maybe lacked
- 9:41Speaker 4: other means of making money because of climate or location,
- 9:46Speaker 4: rocky terrain. I think that's part of what makes opium
- 9:49Speaker 4: so appealing to grow is because it's pretty adaptable or
- 9:51Speaker 4: it can grow and not the most ideal of situation circumstances.
- 9:56Speaker 1: And also it's easy to transport, you know, that's a
- 10:02Speaker 1: big thing. So people began cultivating it all along the
- 10:07Speaker 1: various trade routes through Eurasia which are collectively known today
- 10:11Speaker 1: as the Silk Road. So from the Mediterranean through Asia,
- 10:15Speaker 1: finally to China, opium was growing at this point. Let's
- 10:19Speaker 1: fast forward. That's a very high level look. There's some
- 10:22Speaker 1: excellent history podcast about this growth of opium in ancient
- 10:26Speaker 1: history right to us. If you want to hear them,
- 10:29Speaker 1: we'll send them along. I can safely say that these
- 10:34Speaker 1: are great because we didn't do them, so it's not
- 10:36Speaker 1: us bragging. They're objectively good. But one of the first
- 10:42Speaker 1: and most historically significant conflicts or catastrophes caused directly by opium,
- 10:50Speaker 1: it was a series of conflicts known as the Opium Wars.
- 10:55Speaker 1: The first one occurred in eighteen thirty nine through nineteen
- 10:58Speaker 1: forty two between China and Britain, and the second Opium
- 11:02Speaker 1: War occurred shortly after that in eighteen fifty six to
- 11:06Speaker 1: eighteen sixty. This was sometimes called the Arrow War, and
- 11:11Speaker 1: in that second one, Britain and France teamed up against China.
- 11:15Speaker 1: In each case the Western Powers were victorious, and in
- 11:19Speaker 1: each case the Western Powers were the bad guys.
- 11:23Speaker 2: Categorically, they're the ones that were They were pushing the
- 11:27Speaker 2: opium trade on back onto China because China was trying
- 11:31Speaker 2: to get away or stop the opium crisis that was
- 11:34Speaker 2: occurring within their country.
- 11:36Speaker 4: Now, is this one they would have had like these
- 11:37Speaker 4: opium dens or opium clubs or whatever, where people was
- 11:41Speaker 4: recreationally using it and it had become a problem socially
- 11:44Speaker 4: in the country.
- 11:45Speaker 1: Yeah. There, and in India adjacent to China. What essentially
- 11:51Speaker 1: happen was a trade imbalance. So there was a huge
- 11:54Speaker 1: demand for certain Chinese produced goods, silk, porcelain, stuff like that,
- 12:02Speaker 1: and the West wanted this stuff. It's consumers wanted it.
- 12:07Speaker 1: By consumers at this point for those kinds of goods
- 12:12Speaker 1: I generally mean the really wealthy people, the aristocrats and such.
- 12:16Speaker 1: But the problem was there was no reciprocity. China didn't
- 12:19Speaker 1: want anything that France and Britain were making.
- 12:23Speaker 2: Yeah, but they did.
- 12:24Speaker 1: But Britain particularly did control these opium producing regions, and
- 12:31Speaker 1: they knew that they could engage a more successful trade
- 12:35Speaker 1: if they if they had something that the population of
- 12:39Speaker 1: China wanted, even more importantly, if they could create the
- 12:45Speaker 1: demand for something, if they could make people want it.
- 12:48Speaker 2: And can we just go back and just say they
- 12:51Speaker 2: were controlling those regions through colonial means, yes, through capturing
- 12:55Speaker 2: regions that were resource rich or in this case poppy rich.
- 12:59Speaker 1: Right, the East India Company and one of the most
- 13:04Speaker 1: one of the first globally successful corporations and definitely one
- 13:08Speaker 1: of the most brutal. So the addiction rate amongst the
- 13:13Speaker 1: Chinese population soared. They said, look, we're banning all opium,
- 13:19Speaker 1: don't bring it in. Britain started smuggling it through the
- 13:23Speaker 1: areas they controlled in India, and then they decided to
- 13:28Speaker 1: fight dirty. Ultimately, when they were victorious, what they got
- 13:31Speaker 1: were trade concessions and some subjugation, but they didn't They
- 13:36Speaker 1: did not succeed in colonizing China. It's too big and
- 13:41Speaker 1: not as not as vulnerable in a lot of ways
- 13:45Speaker 1: the other nations were. They also had no interest in
- 13:48Speaker 1: the spread of Western religion.
- 13:50Speaker 2: There you go, and I mean that's a huge deal.
- 13:52Speaker 2: You got indoctrinate as you move forward and colonize. And
- 13:56Speaker 2: we have made two videos on this subject. They're available
- 13:59Speaker 2: on YouTube and our website. One of them is called
- 14:01Speaker 2: have Countries really fought Wars over Opium? And the second
- 14:04Speaker 2: one is do the Opium Wars continue today? And they're
- 14:09Speaker 2: highly informative videos and they pull on a lot of
- 14:12Speaker 2: stuff that other our colleagues have done on the opium
- 14:15Speaker 2: wards in the past.
- 14:17Speaker 1: Right, like stuff you missed in history class. Stuff you
- 14:19Speaker 1: should know all hits, all classics. Hey, Matt, do those questions?
- 14:25Speaker 1: Do those videos still hold up? Would you say they're
- 14:27Speaker 1: still relevant in twenty eighteen?
- 14:28Speaker 2: Yeah, definitely. Well, and these are historical accounts of the
- 14:32Speaker 2: opium wars, so the first one is at least and
- 14:35Speaker 2: the second one really has to do with kind of
- 14:37Speaker 2: what we're talking about today.
- 14:39Speaker 1: Ah, I see, yeah, And speaking of today, what is
- 14:43Speaker 1: the legal status of opium? Right? This thing that launched
- 14:45Speaker 1: so many wars like an evil hellen of Troy. Today,
- 14:51Speaker 1: opium is considered illegal in most countries, including, oddly enough,
- 14:56Speaker 1: the countries where tons and tons literal tons of it
- 14:59Speaker 1: are produced each year, such as Afghanistan. It's still illegal there.
- 15:04Speaker 2: And again you're talking about substance that can fund anything
- 15:08Speaker 2: else in the country because there is so much money
- 15:11Speaker 2: to be made and not a lot of other resources
- 15:13Speaker 2: to be produced.
- 15:14Speaker 1: Yeah, yeah, that's I mean, that is a crucial point here,
- 15:20Speaker 1: I think.
- 15:21Speaker 2: So.
- 15:21Speaker 1: In the US, most opiates and synthetic opioids are considered
- 15:25Speaker 1: scheduled to narcotics by the DEEA Drug Enforcement Administration, and
- 15:30Speaker 1: because of this, they have to be prescribed by a physician.
- 15:33Speaker 1: They are highly regulated currently. Of all the opiates, opiate
- 15:38Speaker 1: or opioid being something derived from actual opium. Of all
- 15:42Speaker 1: of those things, heroin is the only one that is
- 15:45Speaker 1: Schedule one, which means the US government Uncle SAM considers
- 15:49Speaker 1: it that it has a high potential for abuse with little,
- 15:54Speaker 1: relatively little real medicinal value. Like to the US, this
- 16:00Speaker 1: is just a drug that does damage.
- 16:02Speaker 2: Just when it's heroin, and it's so fascinating, which is interesting.
- 16:07Speaker 2: Take half a step and then you've got all the
- 16:09Speaker 2: other drugs we're going to be talking about today.
- 16:11Speaker 1: And of the estimated global opium production, almost half of
- 16:16Speaker 1: it is legally produced for processing into these medicines that
- 16:20Speaker 1: you just mentioned, Matt. Any country can do this. Any
- 16:24Speaker 1: country in the world can apply to the UN. They've
- 16:26Speaker 1: got a thing called the Commission on Narcotic Drugs to cultivate, produce,
- 16:30Speaker 1: and trade opium legally because of this convention signed in
- 16:35Speaker 1: nineteen sixty one, the UN Single Convention on Narcotics Drugs,
- 16:39Speaker 1: and they'll have some supervision from another UN body. But
- 16:44Speaker 1: as of two thousand and one, there were eighteen countries
- 16:47Speaker 1: that do this legally, including countries you might expect like
- 16:52Speaker 1: Turkey or India who had historically produced opium. I'm not
- 16:58Speaker 1: doing a stereotype just based on historical But then other
- 17:01Speaker 1: countries like Australia and the United Kingdom also fall under this,
- 17:06Speaker 1: so they're also producing opium. I just want to be
- 17:09Speaker 1: clear about that. So that's opium. But we're going toward opioids.
- 17:15Speaker 1: What exactly is an opioid?
- 17:18Speaker 4: Yeah, opioids. It's kind of like this overarching umbrella term,
- 17:22Speaker 4: but it's used to describe substances that tick at least
- 17:26Speaker 4: three of the opium receptors in the brain that interact
- 17:29Speaker 4: with them. It's a class of drug that includes illegal,
- 17:34Speaker 4: the illegal narcotic heroin, but it also includes synthetic opioids
- 17:39Speaker 4: like fentanyl and other pain medications that can be obtained
- 17:44Speaker 4: legally with the prescription, like oxycodone. We've got some brand
- 17:48Speaker 4: names here, which is OxyContin, hydrocodone, or vicodin, codeine, morphine,
- 17:54Speaker 4: and tons of more. So, Okay, a little more on
- 17:56Speaker 4: the way the US and the DEA schedules drugs. There's
- 18:00Speaker 4: a system in place. Opioids vary from Schedule one. We
- 18:03Speaker 4: talked about earlier heroin being the only one that is
- 18:06Speaker 4: considered that meaning it has no medicinal use whatsoever and
- 18:08Speaker 4: high potential for abuse, and it goes to Schedule five
- 18:13Speaker 4: and depending on it, it's all depending on this perceived
- 18:16Speaker 4: medical usefulness, abuse potential, safety, drug dependence profile, which sounds
- 18:22Speaker 4: like a very high level way of saying.
- 18:25Speaker 1: Addictability, right, yeah, yeah, yeah, which is different from abuse potential.
- 18:30Speaker 1: Abuse potential is how likely would someone go overboard to
- 18:34Speaker 1: chase a particular effect to the fuzzies, And dependency is
- 18:38Speaker 1: how likely would somebody have to be normal with it?
- 18:41Speaker 4: And dependency and the argument or discussion surrounding that is
- 18:45Speaker 4: a huge part of today's story, which we'll get more
- 18:47Speaker 4: into in a bit. And heroin remains completely illegal to distribute, purchase,
- 18:55Speaker 4: or use outside of any kind of medical research, where
- 18:58Speaker 4: I don't know what that would look like.
- 19:00Speaker 1: Medical research in this sense would mean that a board
- 19:05Speaker 1: like clinical researchers or groups of doctors, often through a
- 19:10Speaker 1: university or government sponsored treatment center, will be able to
- 19:15Speaker 1: access opium or create heroin from it for the purpose
- 19:22Speaker 1: of creating maybe a new opioid, for the purpose of
- 19:26Speaker 1: learning more about how heroin itself affects users and it's.
- 19:31Speaker 2: Kind of similar to the like testing some of the
- 19:35Speaker 2: hallucinogen's right now, sure, see how they affect people with
- 19:39Speaker 2: either post traumatic stress disorder or something.
- 19:41Speaker 1: That's like MDMA R.
- 19:43Speaker 4: Yes.
- 19:44Speaker 1: Yes, And speaking of users, we would say one of
- 19:46Speaker 1: the most important parts of this story, let's learn a
- 19:49Speaker 1: little bit more about usage statistics for opium and opioids.
- 19:54Speaker 1: After a word from our sponsors, Okay, everyone, this is
- 20:03Speaker 1: the point where we dive into some numbers which are
- 20:08Speaker 1: fascinating and damning.
- 20:11Speaker 2: I would say, yeah, and important, and please try do
- 20:13Speaker 2: your best not to gloss over and soak these in.
- 20:16Speaker 2: There are a lot of numbers in this section we're
- 20:18Speaker 2: coming on too, but they are highly important.
- 20:20Speaker 1: So we dug up some relatively recent numbers. Just going
- 20:27Speaker 1: back a few years, the International Narcotics Control Board reported
- 20:32Speaker 1: that in twenty fifteen, ninety nine point seven percent of
- 20:36Speaker 1: the world's hydrocodone, known by its brand name vicodin, was
- 20:40Speaker 1: consumed in the US alone. Zero point three percent of
- 20:45Speaker 1: the world's vicodin is consumed outside of the US.
- 20:48Speaker 4: It's insane.
- 20:49Speaker 2: Do you think that has anything to do with our
- 20:51Speaker 2: ability within this country to promote drugs through advertising?
- 20:55Speaker 1: Yeah, that's true. Yeah, we've mentioned it before, we should
- 20:58Speaker 1: mention it again. Will you break that down for anyone
- 21:00Speaker 1: who didn't hear this in earlier episodes? And is it
- 21:03Speaker 1: from the States.
- 21:04Speaker 2: In a lot of places outside of our grand little
- 21:06Speaker 2: experiment here you are, you're not allowed. It is illegal
- 21:10Speaker 2: to market prescription drugs to people, to try and sell
- 21:15Speaker 2: it as a product to purchase or to use.
- 21:17Speaker 4: Wait, so you're not allowed to have a happy housewife
- 21:19Speaker 4: dancing blissfully across the playground to her child waiting on
- 21:23Speaker 4: the swing sets.
- 21:24Speaker 2: Yes, no matter how many precautions you put at the
- 21:26Speaker 2: end of your ad, you cannot show it in many places.
- 21:28Speaker 4: With neon green grass and perfectly as your blue skies.
- 21:32Speaker 1: And very very vague. It's only allowed in New Zealand.
- 21:39Speaker 1: In the US, bonkers.
- 21:40Speaker 4: And I was even gonna bring up, like, what's that conversation,
- 21:42Speaker 4: like where you decide we're gonna call it vicadin? Is
- 21:45Speaker 4: there any etymology in the names of these drugs ever
- 21:48Speaker 4: at all? I've always wondered the case by case.
- 21:51Speaker 1: Yeah, it's similar to so, because this is private industry,
- 21:55Speaker 1: there's the marketing decision really comes down to conversation between
- 22:01Speaker 1: the CEOs the pr firms and maybe the people who
- 22:05Speaker 1: actually made the drug.
- 22:07Speaker 4: But I don't think the FDA would have any any
- 22:08Speaker 4: way in potential.
- 22:10Speaker 2: Because there because these groups present it to the FDA.
- 22:14Speaker 1: Right, yeah, and the FDA often is a series. They
- 22:17Speaker 1: will have some guidelines about this. But the FDA in
- 22:22Speaker 1: theory on paper and the FDA in practice are two
- 22:25Speaker 1: very very different organizations, unfortunately for most residents of this country.
- 22:30Speaker 1: But yeah, it's it's true. It's a case by case thing,
- 22:33Speaker 1: so they'll have there will be some policy conventions. There's
- 22:37Speaker 1: not a law, but there will be policy conventions such
- 22:39Speaker 1: as you can't name this.
- 22:44Speaker 4: Cansecure havy fun fund pills.
- 22:46Speaker 1: Right right, right, But I would argue that things like
- 22:50Speaker 1: Lyrica are pushing the line on that.
- 22:52Speaker 4: It sounds nice, yes right wow, just saying it out
- 22:55Speaker 4: loud makes me have a warm, fuzzy feeling.
- 22:57Speaker 1: Right, So it's it does go down to marketing. If
- 23:01Speaker 1: you are listening to this and you are you have
- 23:03Speaker 1: participated the naming of a drug, we would love to
- 23:06Speaker 1: hear your process.
- 23:07Speaker 2: Absolutely, yeah, Tyland, all get at us right.
- 23:11Speaker 1: Exceedrin's a good one because he's had the root of
- 23:13Speaker 1: excel in there. That's an excellent. So throughout twenty sixteen,
- 23:18Speaker 1: regardless of what the names for these drugs were, there
- 23:21Speaker 1: were more than sixty three thousand, six hundred overdose deaths
- 23:24Speaker 1: in the US. Of those, sixty three thousand, six hundred
- 23:29Speaker 1: forty two, two hundred and forty nine involved an opioid,
- 23:33Speaker 1: that's sixty six percent. That's over sixty six percent, and
- 23:37Speaker 1: that if we want to math it out a little bit,
- 23:40Speaker 1: that equates to an average of one hundred and fifteen
- 23:43Speaker 1: overdose deaths just from opioids every single day in twenty sixteen.
- 23:48Speaker 4: Do we have a statistic as to whether there were
- 23:51Speaker 4: street opioids or prescription opioids, and I would love to
- 23:55Speaker 4: see a breakdown of that. Probably hard to.
- 23:57Speaker 1: Tell, well, yeah, because they gather that information, they assess
- 24:00Speaker 1: cause of death, and sometimes it might be difficult to
- 24:03Speaker 1: figure out how that got in their system. So I bet,
- 24:06Speaker 1: I bet you if we drill down enough we can
- 24:09Speaker 1: we can find something there, or we can find a
- 24:11Speaker 1: good guess. But that statistic is just some sort of opioid,
- 24:16Speaker 1: But still it's they're dead.
- 24:19Speaker 4: But given the prescription rate and the numbers, it sure
- 24:24Speaker 4: feels like a big chunk of those are probably legally
- 24:27Speaker 4: obtained and prescribed or sold by someone who legally obtained
- 24:32Speaker 4: and prescribed them to someone who maybe shouldn't have had.
- 24:34Speaker 1: Them from what they call pill mills pill mills.
- 24:38Speaker 4: Considering those numbers, we said at the top of the
- 24:39Speaker 4: show about how many people in this country rely on
- 24:42Speaker 4: prescription medication.
- 24:44Speaker 1: Yeah, and we do have stats on the number of
- 24:48Speaker 1: opioid prescriptions in nineteen ninety two. This is troubling. It
- 24:52Speaker 1: goes to your question about how we can ascertain which
- 24:56Speaker 1: particular type of opioid people were trying, like street or prescription.
- 25:00Speaker 1: Nineteen ninety two, there were one hundred and twelve million
- 25:02Speaker 1: prescriptions written for some sort of opioid. By twenty twelve,
- 25:07Speaker 1: that had peaked to two hundred and eighty two million.
- 25:10Speaker 1: I'm sorry what, Yeah, per year, not per day. Well overdoubled. Yeah,
- 25:15Speaker 1: well overdoubled. The good news is it began to decline
- 25:18Speaker 1: after that by but not by that much. Two hundred
- 25:21Speaker 1: something million is the new normal. Now in twenty sixteen,
- 25:25Speaker 1: the number had fallen to two hundred and thirty six million,
- 25:28Speaker 1: so it's still more than doubled.
- 25:32Speaker 2: My gosh.
- 25:33Speaker 4: Yeah, and surely it's not a product of some kind
- 25:36Speaker 4: of massive population boom, right. You know, we definitely obviously
- 25:39Speaker 4: know that our population is growing, but certainly not by
- 25:42Speaker 4: that kind of number.
- 25:43Speaker 2: And all you're asking about a number that you could
- 25:46Speaker 2: point to to how many prescription deaths there have been.
- 25:49Speaker 2: So from nineteen ninety nine up until twenty fifteen, there
- 25:53Speaker 2: were roughly an estimated one hundred and eighty three thousand
- 25:58Speaker 2: deaths from prescription overdoses opiate overdose, which.
- 26:02Speaker 1: Means that's what the average of ninety one overdose.
- 26:07Speaker 2: Deaths per day since ninety nine.
- 26:10Speaker 1: And as a result, to put this in perspective, this
- 26:14Speaker 1: means we have we have a lot of folks who
- 26:17Speaker 1: listen to this show while they're driving. Yeah, so this
- 26:20Speaker 1: might be good news for you. You are more likely
- 26:24Speaker 1: to die of an opioid overdose than a car crash. Yeah,
- 26:29Speaker 1: so you're safer in your car at least.
- 26:32Speaker 2: Man, you know, driving and work today. Four cars ahead
- 26:35Speaker 2: of me, some dude was trying to get off at
- 26:37Speaker 2: the fourteenth Street exit coming south on eighty five. This
- 26:40Speaker 2: is for all you Atlanta listeners. And as he's trying
- 26:44Speaker 2: to get over, he's trying to do it, you know,
- 26:45Speaker 2: right at the end, right before there's the guardrail and
- 26:47Speaker 2: every one of those and he couldn't make it. So
- 26:50Speaker 2: he like swung his car back to the left, made
- 26:52Speaker 2: another car get out of the way of him, and
- 26:55Speaker 2: ran into a truck just a couple of cars ahead
- 26:58Speaker 2: of me.
- 26:58Speaker 4: And so even a in Atlanta traffic, you're safer in
- 27:01Speaker 4: your car. You are taking prescription opius.
- 27:04Speaker 2: Yes, in a crazy place like this.
- 27:07Speaker 1: Statistically speaking at least, right, but yeah, that's that's a
- 27:12Speaker 1: sobering point. And as of twenty eighteen, more than two
- 27:16Speaker 1: million American residents have become either dependent on, or have
- 27:20Speaker 1: abused prescription pain pills and street drugs. So luckily at
- 27:25Speaker 1: least that's the total for the illegal trade as well
- 27:29Speaker 1: as the quote unquote legal one. And we have to
- 27:32Speaker 1: ask ourselves, at what point does this become an epidemic.
- 27:36Speaker 1: Most would argue that having this many people addicted to
- 27:39Speaker 1: some derivative of opium or a similar narcotic means we're
- 27:43Speaker 1: already in a crisis. But if that doesn't tip the scale,
- 27:47Speaker 1: if two million is not enough, then what does move
- 27:49Speaker 1: the needle? More deaths, a higher rate of addiction. Is
- 27:52Speaker 1: it a crisis when it's five million people? Is it
- 27:55Speaker 1: not a crisis until it's ten million.
- 27:58Speaker 2: Yeah, who decides that?
- 28:01Speaker 1: Well, I think recently the current president did declare that
- 28:06Speaker 1: there was a crisis.
- 28:07Speaker 2: Right Well, there have been cries to call it a
- 28:10Speaker 2: crisis for a long time, and the news, the media
- 28:14Speaker 2: has been calling it a crisis for years and years.
- 28:18Speaker 4: But didn't he stop just short of there being really
- 28:20Speaker 4: any real action behind it? Like I think declaring a
- 28:24Speaker 4: state of emergency or something allows some kind of federal
- 28:27Speaker 4: money to kick in to help mitigate a problem. And
- 28:30Speaker 4: I think his declaration stopped just short of anything real happening.
- 28:35Speaker 4: It was more of a symbolic gesture than anything.
- 28:38Speaker 2: Well, yeah, it's a question of do we use tax
- 28:40Speaker 2: money to actually combat it or do we say, yes,
- 28:43Speaker 2: it's a crisis and let's get more private institutions working
- 28:46Speaker 2: on it.
- 28:46Speaker 1: And right now that fight is going state by state,
- 28:50Speaker 1: and it leads us to another question, how did this
- 28:53Speaker 1: all happen? What caused this? It's sort of like that
- 28:58Speaker 1: trope in film and televis where you get to a
- 29:01Speaker 1: freeze frame and someone you hear a voiceover say, you're
- 29:04Speaker 1: probably wondering how I got here? That's our question? What
- 29:07Speaker 1: brought us here? Here's where it gets crazy. According to
- 29:13Speaker 1: numerous critics, policy researchers, government officials, medical experts, and more,
- 29:22Speaker 1: the cause of the current opioid epidemic isn't solely the
- 29:26Speaker 1: fault of say, like some illegal drug cartel over the
- 29:32Speaker 1: border or in the Golden Triangle somewhere. It's not street
- 29:36Speaker 1: level dealers like Pooky in the wire. Instead, they argue
- 29:39Speaker 1: the blame for the present crisis falls squarely at the
- 29:42Speaker 1: feet of the pharmaceutical industry, the lobbyist it employees, and
- 29:47Speaker 1: the government officials with whom these lobbyists interact. I mean,
- 29:50Speaker 1: if we take a closer look, nearly seventy five percent
- 29:54Speaker 1: of people who are receiving treatment for heroin addiction didn't
- 29:58Speaker 1: just start doing heroin. They didn't wait up one day
- 30:00Speaker 1: and say, you know what, carpe dum. They began their
- 30:05Speaker 1: addiction by being prescribed opioid painkillers.
- 30:11Speaker 4: Yeah, typically for.
- 30:12Speaker 1: A painkilling thing, right. And these are often people who
- 30:15Speaker 1: don't have a history of drug abuse.
- 30:17Speaker 2: Yeah, And many times it has to do with being
- 30:19Speaker 2: prescribed a certain amount of opioid, so over a threshold
- 30:24Speaker 2: of days. I think the safe threshold is like seven
- 30:28Speaker 2: or something around that, and many of these begin when
- 30:31Speaker 2: you get like two weeks three weeks worth of prescription painkillers.
- 30:36Speaker 1: Yeah, and the weird thing is that this statistic that
- 30:42Speaker 1: seventy five I think the number may have increased to
- 30:44Speaker 1: eighty percent now that the vast majority of people are
- 30:48Speaker 1: in treatment for heroin addiction in the US started heroin
- 30:54Speaker 1: after they could no longer get legal opioid prescriptions. This
- 30:58Speaker 1: is absolutolutely a well known fact, but it still has
- 31:03Speaker 1: yet to stop the rise in opioid prescriptions for pain relief.
- 31:08Speaker 1: That over the past ten years, the number of prescriptions
- 31:12Speaker 1: handed out has risen by three hundred percent.
- 31:15Speaker 4: Well, get this. There's an article from the Washington Post
- 31:17Speaker 4: from twenty fifteen, so not incredibly up to date, but
- 31:21Speaker 4: still The headline is why a bag of heroin costs
- 31:24Speaker 4: less than a pack of cigarettes, And it has a
- 31:27Speaker 4: map for the entire country showing about how much a
- 31:31Speaker 4: bag of heroin costs. And by bag, we're saying that's
- 31:33Speaker 4: that's about a dose. Maybe it's two doses, I'm not sure,
- 31:36Speaker 4: point being it's between seven and ten dollars for an
- 31:43Speaker 4: amount of heroin that could potentially kill you. It would
- 31:45Speaker 4: be enough to completely put you put your button, the dirt,
- 31:50Speaker 4: you know what I mean.
- 31:51Speaker 1: But how much does that how much does a heavy
- 31:54Speaker 1: heroin user use per day? Surely more than water two doses, absolutelysolutely.
- 32:00Speaker 4: And here's the thing too, I just looked up OxyContin
- 32:03Speaker 4: pill price and it says when legally sold, a ten
- 32:06Speaker 4: milligram tab of oxycotton is about a buck twenty five,
- 32:10Speaker 4: and an eighty milligram tablet will cost six dollars. When
- 32:14Speaker 4: illegally sold on the street, it can cost between ten
- 32:18Speaker 4: dollars and eighty dollars for one pill, depending on the dose,
- 32:22Speaker 4: So it's usually about a dollar a milligram, So an
- 32:25Speaker 4: eighty milligram oxy content is about eighty dollars.
- 32:29Speaker 1: And a tab is just a pill a pill, Okay.
- 32:32Speaker 4: So you can see maybe if you can't get it
- 32:35Speaker 4: legally prescribed and you're relying on those pill mills or
- 32:39Speaker 4: buying it illegally from someone who does have the prescription,
- 32:41Speaker 4: which is certainly how a lot of this stuff gets
- 32:42Speaker 4: into circulation, you could see the attraction of buying those
- 32:48Speaker 4: seven dollars bags of heroin if you're really addicted to
- 32:51Speaker 4: that particular you know, buzz yeah.
- 32:55Speaker 1: And then people would say, well, I'm not. I'm doing
- 32:58Speaker 1: this as a stopgap, right, and I'm not going to
- 33:01Speaker 1: shoot it up. I'm not going to take it intravenously.
- 33:03Speaker 1: I'm not going to insulfate or whatever. I'm just going
- 33:05Speaker 1: to maybe smoke it or snort it. Yeah yeah, right,
- 33:09Speaker 1: maybe get to snorting it, but never shooting it. So
- 33:12Speaker 1: one of the big There's some demographics that fall into
- 33:16Speaker 1: this too that we would be remiss if we didn't mention.
- 33:18Speaker 1: We'll get to them by the end of the episode,
- 33:20Speaker 1: but for now we can say that opiate manufacturers know
- 33:27Speaker 1: how much money is at stake. They've spent more than
- 33:31Speaker 1: eight hundred and eighty million over the past ten years
- 33:35Speaker 1: just to not to make new drugs, but just to
- 33:37Speaker 1: keep control over the making and distribution of these substances.
- 33:44Speaker 2: Yeah, we almost said products, but it just makes you
- 33:46Speaker 2: want to bomb it a little bit, right, It's true.
- 33:49Speaker 1: And this money, where did this massive amount of cash
- 33:53Speaker 1: come from? Where do we get this number? It comes
- 33:55Speaker 1: from their lobbying and campaign contributions. And this has been
- 33:59Speaker 1: used in large settlements with anyone looking to challenge what
- 34:06Speaker 1: is commonly called big pharma. I know, when you hear
- 34:09Speaker 1: that phrase makes it easy to dismiss this as some
- 34:13Speaker 1: looney tunes conspiracy theory. But there is a huge industry,
- 34:16Speaker 1: it's real. Call it big pharma and call it whatever
- 34:19Speaker 1: you want. It's not going to stop them.
- 34:21Speaker 2: Yeah. A small group of very profitable companies.
- 34:25Speaker 4: Yeah, very powerful, and they have, you know, a lot
- 34:29Speaker 4: of money for lobbyists to wield legislative influence and make
- 34:33Speaker 4: sure that that pill money keeps on a flowing.
- 34:37Speaker 1: Yeah. In the nineteen nineties, pharmaceutical companies reassured the medical community, doctors, researchers, hospitals,
- 34:45Speaker 1: medical institutions that patients would not become addicted to prescription
- 34:50Speaker 1: opioid pain relievers. This is different from heroin. This is
- 34:56Speaker 1: a morphine, right, or opium. This is FDA proved this.
- 35:01Speaker 1: We have specifically made this to mitigate or ameliorate some
- 35:06Speaker 1: of those concerns about the possibility of addiction. And then
- 35:10Speaker 1: healthcare providers began to prescribe them at these drugs rather
- 35:15Speaker 1: at greater rates. And when they say they persuaded them
- 35:17Speaker 1: and reassured them that that's where money comes into play.
- 35:21Speaker 1: It's a little bit of a euphemistic thing.
- 35:22Speaker 4: Well, you know our mousepads, right, Yeah.
- 35:26Speaker 2: I think we just have to say right here at
- 35:28Speaker 2: the top that there are a lot of people everywhere
- 35:32Speaker 2: on this planet that are in constant pain that just
- 35:36Speaker 2: kind of live in some kind of pain. Yes, sure
- 35:40Speaker 2: that exists, and it subsists, and the invention of these
- 35:46Speaker 2: products what is and was kind of this amazing miracle
- 35:51Speaker 2: thing for people who are just constantly in pain. You mean,
- 35:53Speaker 2: I could take a pill and I don't hurt always.
- 35:57Speaker 1: Right, It's not a cure, but it's a it's not
- 36:01Speaker 1: it lessens the curse. Yeah, chronic and curable pain.
- 36:04Speaker 2: It almost the idea of it at least gives the
- 36:08Speaker 2: lives back to people who are taking it.
- 36:10Speaker 1: Right, That's powerful.
- 36:12Speaker 2: So you can see you can kind of see here
- 36:14Speaker 2: where a lot of it is mental from the manufacturers
- 36:21Speaker 2: to the end user of I'm doing something good or
- 36:24Speaker 2: this is helping me, this is giving me my life back. Yeah,
- 36:27Speaker 2: I just want to throw that.
- 36:28Speaker 1: In that that's a brilliant point. In the nineteen nineties,
- 36:32Speaker 1: everyone wanted to believe these statements, yes, by the pharmaceutical companies,
- 36:37Speaker 1: and perhaps you know what, you know what, man, perhaps
- 36:40Speaker 1: they believed it too. Yeah, let's just look, maybe they
- 36:43Speaker 1: did either way, whether they were purposely being deceptive or
- 36:48Speaker 1: whether they honestly just somehow didn't do even the most
- 36:54Speaker 1: cursory research on this stuff. Whatever happened, it led to
- 36:59Speaker 1: the misuse of these medications and eventually became clear that
- 37:03Speaker 1: they were highly addictive, and anyone who said otherwise was
- 37:08Speaker 1: either lying or cartoonishly wrong. And first, it is valid
- 37:14Speaker 1: for defenders of these companies to say you cannot blame
- 37:17Speaker 1: drug companies for legally selling something the FDA approved, But
- 37:22Speaker 1: the problem with that is pharmaceutical companies didn't just sell
- 37:26Speaker 1: these opioids. They also brutally suppressed legislation that would have
- 37:31Speaker 1: limited addiction among patients, including, for instance, a bill in
- 37:36Speaker 1: Tennessee that was designed to reduce the number of newborns
- 37:40Speaker 1: who were born addicted to opiates. For some reason, the
- 37:44Speaker 1: drug companies heavily lobbied to kill that bill and successfully.
- 37:49Speaker 1: In New Mexico, there was another proposed bill that was
- 37:52Speaker 1: supposed to limit the initial prescription of opioids for acute
- 37:55Speaker 1: pain to your PA point MATT to seven days to
- 37:58Speaker 1: a week, and that make addiction less likely and produce
- 38:02Speaker 1: fewer leftover.
- 38:03Speaker 2: Pills, which is such a idea a.
- 38:05Speaker 1: Big problem, but that legislation got killed as well. And
- 38:10Speaker 1: let's be even more fair here, they didn't just kill
- 38:14Speaker 1: certain bills or proposals. You don't want to make it
- 38:16Speaker 1: sound like that they were instrumental. In fact, this might
- 38:21Speaker 1: surprise some people in supporting several key pieces of legislation
- 38:25Speaker 1: related to opioids. They were huge fans of a bill
- 38:30Speaker 1: in Maine that required insurers to cover the company's abuse
- 38:35Speaker 1: deterrent painkillers. Do you like that phrase abuse deterrence?
- 38:39Speaker 2: Right? Wait, what are what are these abuse deterrent painkillers?
- 38:43Speaker 2: This is a special version.
- 38:45Speaker 1: Well, the idea is that they aren't there, you're less
- 38:49Speaker 1: likely to get addicted again. That's how they were sold.
- 38:53Speaker 4: Things like time release kind of like stuff like that,
- 38:56Speaker 4: because I know that like early on you would always
- 38:58Speaker 4: read that with oxy content, for example, you could crush
- 39:02Speaker 4: them up and snort them like we were talking about.
- 39:04Speaker 4: And we found out that the that the companies knew
- 39:07Speaker 4: that was being done, that there was that kind of abuse.
- 39:10Speaker 4: But then later there were versions of them that you
- 39:13Speaker 4: could not do that with. They had some special coding
- 39:16Speaker 4: that you could not break or it would fundamentally change
- 39:19Speaker 4: the nature of the drug, and it prevented you from
- 39:22Speaker 4: doing this is that the kind of stuff you're talking about.
- 39:24Speaker 1: Yeah, those would be a couple of examples. And I
- 39:28Speaker 1: don't know if there's anything that's industry wide with that,
- 39:32Speaker 1: because again, these are all private companies, but it would
- 39:34Speaker 1: be stuff like time release, for instance, or something that
- 39:38Speaker 1: coding you mentioned is fascinating everyone to read more about that.
- 39:42Speaker 1: But I'm glad you're bringing up specific examples because we'll
- 39:45Speaker 1: get to some specific examples of instances wherein these pharmaceutical
- 39:52Speaker 1: companies became let's say, controversial. Sure, after a word from
- 39:56Speaker 1: our sponsors. All right, twenty seventeen.
- 40:06Speaker 2: Day, I am there. Let's see what's going on.
- 40:08Speaker 1: It's it's it's about a year ago.
- 40:10Speaker 4: Oh, oh, you're right, Okay, much much the same.
- 40:14Speaker 1: What's going on?
- 40:16Speaker 4: First? We love? What what season of Game of Thrones
- 40:19Speaker 4: are we on at that point?
- 40:20Speaker 3: Right?
- 40:20Speaker 1: Right? Is it?
- 40:21Speaker 4: We're still wrapping up the last one?
- 40:23Speaker 2: Right?
- 40:23Speaker 1: I think so? Yeah? And you know, the four of
- 40:28Speaker 1: us are all still devastatingly handsome, h reasonably witty.
- 40:33Speaker 4: Man, you devil, I'm a sly one.
- 40:36Speaker 2: Right.
- 40:37Speaker 1: And there's also a senator named Claire mccaskell, Democrat out
- 40:42Speaker 1: of Missouri, who releases a report about an Arizona based
- 40:47Speaker 1: drug maker named in ciss I n s y S. Yes,
- 40:52Speaker 1: they make an opioid called Subsis s U b s ys.
- 40:59Speaker 1: It contains and in this senator's support again this twenty seventeen,
- 41:05Speaker 1: there are a ton of internal documents from the company,
- 41:09Speaker 1: from Insists itself describing how it works to get over
- 41:13Speaker 1: these barriers called prior authorizations. Subsists the drug is meant
- 41:19Speaker 1: for one thing, and one thing alone, for cancer related pain.
- 41:24Speaker 1: If you want to get it for anything else, you
- 41:28Speaker 1: have to get prior authorization from your doctor. So it
- 41:33Speaker 1: turns out internally Insists had a whole department within the
- 41:38Speaker 1: company just for doing this, just forgetting these prior authorizations.
- 41:42Speaker 2: And it was not above board.
- 41:44Speaker 1: No, no, no. The employees in this department would call
- 41:48Speaker 1: pharmacy benefit managers, who are in charge of these prior authorizations.
- 41:53Speaker 2: You've got to love the terms.
- 41:54Speaker 1: Yeah, and they would pretend they were with a doctor's
- 41:59Speaker 1: office to get the sign off for Subsists to be
- 42:04Speaker 1: prescribed to a patient who did not have cancer.
- 42:08Speaker 2: Wow.
- 42:09Speaker 1: So my question is is that not fraud?
- 42:13Speaker 2: I think it is. I would argue that it was
- 42:16Speaker 2: like it like.
- 42:16Speaker 1: The definition of fraud it's illegal for us to call
- 42:20Speaker 1: a pharmacy and pretend to be a doctor's office.
- 42:22Speaker 2: Yeah, m all right, is it all right? We see
- 42:28Speaker 2: you in sis.
- 42:29Speaker 1: And then there's there's another example, which is one that
- 42:32Speaker 1: I think really stood out to all of us. This
- 42:35Speaker 1: company is one of the most well known cases of
- 42:38Speaker 1: we're going to be alliterative pharmaceutical perfidy.
- 42:41Speaker 2: Oh wait, word of the day, perfety. What does it mean?
- 42:46Speaker 1: It's deceitful, untrustworthy, treacherous, duplicitous, perfidy.
- 42:51Speaker 2: You're word of the day.
- 42:52Speaker 1: Okay, thank you, Matt So. Purdue Pharma is a company
- 43:00Speaker 1: that aggressively marketed oxy cotton and they made it. They
- 43:05Speaker 1: made it, and that's the brand name for Is it
- 43:08Speaker 1: hydrocodone or is that vicotin?
- 43:10Speaker 4: I think it's oxy codone.
- 43:12Speaker 1: Isn't it oxy codone? I think yes, you were correct.
- 43:15Speaker 1: Thank you. Oxy Conton, marketed by Purdue, was claimed to
- 43:22Speaker 1: be one of those things that was going to be
- 43:24Speaker 1: less addictive, right than a heroin and have all same
- 43:28Speaker 1: great benefits, same great taste, far fewer calories, very American
- 43:32Speaker 1: in the marketing, right, but they also claimed The company
- 43:38Speaker 1: claimed that they were unaware of the growing abuse of
- 43:42Speaker 1: oxy contin, which I think is also called in some
- 43:46Speaker 1: some parts of Appalachia at least is called hillbilly heroin.
- 43:50Speaker 4: It is right, and I spoiled a little bit of
- 43:52Speaker 4: this earlier, but let's get into some details here.
- 43:55Speaker 1: So it turns out that a copy of a confidential
- 43:59Speaker 1: Justice Toon Apartment report surfaced, and it shows that federal
- 44:03Speaker 1: prosecutors investigating Purdue found that Purdue knew about quote significant
- 44:09Speaker 1: abuse of this drug, in particular in the first few
- 44:13Speaker 1: years after they introduced it in nineteen ninety six, and
- 44:16Speaker 1: then they covered it up. They were aware that people
- 44:20Speaker 1: would do insane things to satisfy oxy cotton. They saw
- 44:24Speaker 1: that pills were being sold illegally and then crushed and
- 44:28Speaker 1: snorted or cut with other stuff, you know, and that
- 44:31Speaker 1: they would be stolen from pharmacies, sometimes in violent robberies.
- 44:35Speaker 4: Yeah, like drugstore cowboy style if you've ever seen that
- 44:37Speaker 4: Gus van Zam movie.
- 44:39Speaker 1: And then they would some doctors were being charged with
- 44:42Speaker 1: just selling prescriptions. Just come into my pill mill where
- 44:46Speaker 1: the address changes every few years, give me fifty bucks,
- 44:50Speaker 1: tell me what you want.
- 44:50Speaker 2: It's despicable, and guess what they did. They went on
- 44:54Speaker 2: ahead they pushed forward and they said, no, no, no
- 44:57Speaker 2: oxy cotton. Guys, this is less own to addiction then
- 45:01Speaker 2: other prescription opioids. It's the better choice for you and
- 45:04Speaker 2: your family and then family.
- 45:08Speaker 1: Yeah, exactly. And today Purdue maintains that it had absolutely
- 45:14Speaker 1: no knowledge of the abuse potential until two thousand, again
- 45:17Speaker 1: despite internal memos from the higher ups, multiple memos and
- 45:22Speaker 1: conversations that clearly contradict this.
- 45:25Speaker 2: Can we go ahead and just talk about the Sackler family, Yeah.
- 45:30Speaker 1: Lay it on the meat.
- 45:30Speaker 2: This is just really fast.
- 45:31Speaker 1: So the Sackler family, ultimately they're the owners of Purdue.
- 45:35Speaker 2: Yeah, there's there are about twenty individuals that share the
- 45:39Speaker 2: wealth of this one family that owns Purdue, and it's
- 45:44Speaker 2: it's fascinating. I think they have a net income or
- 45:47Speaker 2: a net family worth of around thirteen billion dollars right now,
- 45:51Speaker 2: at least that's according to Forbes.
- 45:54Speaker 1: They're eating pillion dollars.
- 45:56Speaker 4: The you would say that, I love that. Yeah.
- 46:00Speaker 2: Yes, they bought this this drug manufacturer a long time
- 46:04Speaker 2: ago in nineteen fifty two, the one that was just
- 46:06Speaker 2: kind of around.
- 46:07Speaker 4: It's fledgling, young upstock drug manufacturyarium.
- 46:14Speaker 2: And they were making things again. According to Forbes like
- 46:18Speaker 2: uh ear wax remover and laxative.
- 46:20Speaker 4: Tonics, no doubt.
- 46:21Speaker 2: Yes, you know. Thing well, I mean it's nineteen fifty two.
- 46:24Speaker 2: They're making they're making prescription drugs and stuff like that
- 46:26Speaker 2: to cocaine and.
- 46:28Speaker 1: I'm sure mother's little helper, right but.
- 46:32Speaker 2: Yeah, But apparently they didn't have really much going on,
- 46:36Speaker 2: as you know, a way of bringing money into the
- 46:38Speaker 2: company until they made this drug oxycont and in nineteen
- 46:43Speaker 2: ninety five that's when they officially were making it or
- 46:45Speaker 2: like made it, and from that point on that was
- 46:49Speaker 2: the thing. I mean, it's literally the cash cow or
- 46:51Speaker 2: the heroin that they came upon.
- 46:53Speaker 4: More like oxy Koching.
- 46:55Speaker 1: I mean, there we go, yes, yes, worth it.
- 46:59Speaker 2: Yeah, but they're the number nineteen most wealthy family in
- 47:03Speaker 2: the world right now.
- 47:04Speaker 1: Insane and they made that money. They made the bulk
- 47:06Speaker 1: of it off of this particular.
- 47:11Speaker 4: Product.
- 47:12Speaker 2: Yeah. Oh I'm sorry, number nineteen in America.
- 47:15Speaker 1: Oh okay, world, there we go. You know, it's still
- 47:19Speaker 1: kudos to you Sacklers.
- 47:22Speaker 4: If you want to dig a little deeper into that,
- 47:23Speaker 4: there's an article in The New Yorker with a fabulous
- 47:26Speaker 4: headline it's the family that built an Empire of Pain.
- 47:30Speaker 4: The Sackler dynasty's ruthless marketing of painkillers has generated billions
- 47:34Speaker 4: of dollars and millions of addicts.
- 47:37Speaker 1: That's a great title and surprisingly accurate. Let's look at
- 47:40Speaker 1: those distribution statistics. Between twenty seven and twenty sixteen, the
- 47:44Speaker 1: most widely prescribed opioid was Actually it was an oxycodone,
- 47:49Speaker 1: not this time. No, it's hydrocodon vicated, which you might
- 47:52Speaker 1: remember from some of EM and M's earlier lyrics.
- 47:56Speaker 4: Yeah, and you know movies from the eighties.
- 47:59Speaker 2: Yes, or you know, just any of your relatives or
- 48:03Speaker 2: friends who have been prescribed it. Yeah.
- 48:05Speaker 1: In twenty sixteen, six point two billion hydrocodone pills were
- 48:09Speaker 1: distributed across this nation. Six point two billion oxycodones. Not
- 48:14Speaker 1: even the OxyContin. Rather, it is not even the second
- 48:19Speaker 1: most prevalent. The second most prevalent is another version of oxycodone, percocet.
- 48:25Speaker 1: That that topped out at five billion tablets or pills
- 48:31Speaker 1: distributed in the US.
- 48:32Speaker 2: Oh my god.
- 48:34Speaker 1: People have been taking notice, you know, not just not
- 48:37Speaker 1: just us, not just a couple of reporters here and there,
- 48:41Speaker 1: but the government too. In two thousand and six, after
- 48:45Speaker 1: a four year investigation, the Justice Department and the prosecutors
- 48:50Speaker 1: recommended that three top executives at Purdue be indicted on
- 48:55Speaker 1: felony charges, including conspiracy to defraud the Unite Kid States.
- 49:02Speaker 1: And this would have resulted in prison time if these
- 49:05Speaker 1: people have been convicted.
- 49:07Speaker 2: This okay, so it just go ahead. That reminds me
- 49:10Speaker 2: of maybe the market crash of two thousand and seven,
- 49:14Speaker 2: two thousand and eight. Yeah, where all the guys in
- 49:16Speaker 2: charge were supposed to get indicted and and charged and
- 49:19Speaker 2: they'd be in trouble.
- 49:20Speaker 3: Mm hmmm.
- 49:20Speaker 1: Yeah, I'm glad it reminds you of that.
- 49:22Speaker 2: So I'm hopefully just just like that situation, all those
- 49:26Speaker 2: guys went to prison, right, oh boy?
- 49:28Speaker 1: Yeah, okay, So what happened was officials in the George W. H.
- 49:34Speaker 1: Bush administration did not support this prosecutorial move.
- 49:39Speaker 2: Oh.
- 49:40Speaker 1: Instead, they settled the case in two thousand and seven.
- 49:43Speaker 1: And we have a quote from a New York Times
- 49:46Speaker 1: article on this debacle.
- 49:49Speaker 2: Some would call it Prdue Pharma pleaded guilty to a
- 49:53Speaker 2: felony charge of misbranding and oxyconton while marketing the drug
- 49:56Speaker 2: by misrepresenting, among other things, it's risk of addiction and
- 50:00Speaker 2: potential to be abused. So there were three executives, the
- 50:03Speaker 2: company's chief executive, Michael Friedman, it's top medical officer, doctor
- 50:06Speaker 2: Paul D. Goldenheim, and mister Udell, a gentleman who died
- 50:10Speaker 2: in twenty thirteen. All of these guys pleaded guilty to
- 50:13Speaker 2: misdemeanor misbranding. Yeah, and it solely held them liable as
- 50:18Speaker 2: purdues Purdue pharmas responsible executives and did not accuse them
- 50:24Speaker 2: of any wrongdoing.
- 50:26Speaker 1: And the company had to pay.
- 50:28Speaker 2: Oh.
- 50:29Speaker 1: Along with the executives paid six hundred and thirty four
- 50:33Speaker 1: point five million dollars in fines, and although they did
- 50:36Speaker 1: not go to jail, they were required to perform get
- 50:40Speaker 1: this community service.
- 50:42Speaker 2: No member.
- 50:43Speaker 1: By the way, the prosecutors did not accuse any Sackler
- 50:47Speaker 1: family members of wrongdoing.
- 50:49Speaker 4: Let's just remember that, you know, six hundred and thirty
- 50:51Speaker 4: four mill seems like a ton of cash, but this
- 50:54Speaker 4: family is worth upwards of thirteen bill.
- 50:57Speaker 2: Well and at the time the breaking in about one
- 51:01Speaker 2: point six billion dollars a year with their farm industry.
- 51:05Speaker 1: So it's like with banking regulation, is that just the
- 51:07Speaker 1: cost of doing business at this point?
- 51:09Speaker 2: I mean, it's a huge cost. It's like over one
- 51:12Speaker 2: third of your your cost of doing business.
- 51:14Speaker 1: But still, but those payments are negotiable too. It's essentially
- 51:18Speaker 1: a layaway payment plan or they can they can appeal
- 51:23Speaker 1: that and see what they did make a settlement. Yes,
- 51:26Speaker 1: that's the problem. So they are on the hook some
- 51:29Speaker 1: how to pay it. But once that stuff gets out
- 51:32Speaker 1: of the news, you would be surprised how amenable both
- 51:35Speaker 1: parties can be behind the scenes.
- 51:37Speaker 4: And yet, Ben, if I get a parking ticket, I
- 51:40Speaker 4: gotta pay that thing in full. Yeah, or any kind
- 51:43Speaker 4: of moving violation or misdemean whatever it might be. Like,
- 51:47Speaker 4: I've been the court only for parking and traffic stuff,
- 51:50Speaker 4: but you have to pay it before you leave unless
- 51:53Speaker 4: you give some kind of crazy mitigating circumstances.
- 51:58Speaker 2: You know your your local government appreciates it's your business.
- 52:00Speaker 4: Well, yeah, that's how it feels. But it's so crazy
- 52:02Speaker 4: to me thinking about the back room scenarios that would
- 52:05Speaker 4: go into scheduling payments for an astronomical amount like this
- 52:09Speaker 4: when the company can totally afford it. I don't know,
- 52:12Speaker 4: it's just rubs me the wrong way.
- 52:16Speaker 2: Sacklers.
- 52:18Speaker 1: And there's a pretty interesting anecdote that I think you
- 52:23Speaker 1: found though, about protest with Purdue and the Sacklers.
- 52:27Speaker 4: Yeah, I think we've talked about this on another episode previously,
- 52:29Speaker 4: but I think this is a really nice way to
- 52:31Speaker 4: tie this thing up. Earlier this year, an art gallery
- 52:36Speaker 4: owner in Connecticut got arrested after he placed an enormous
- 52:40Speaker 4: sculpture of a heroin spoon. You might have seen this
- 52:44Speaker 4: in movies. So you take a spoon and you bend
- 52:47Speaker 4: it backwards on top of itself so that you can
- 52:49Speaker 4: take the powdered heroin. You place it in the spoon,
- 52:51Speaker 4: and you light a match or a lighter or a candle,
- 52:55Speaker 4: and it boils it up or burn. You put water
- 52:58Speaker 4: in it and it becomes an inject double substance as
- 53:01Speaker 4: opposed to a powder and this notion of being addicted,
- 53:04Speaker 4: it's kind of an icon of addiction to heroin, very specifically.
- 53:07Speaker 4: So this gallery owner placed an enormous sculpture of one
- 53:12Speaker 4: of these heroin spoons right outside in the walkway of
- 53:16Speaker 4: the home office of Purdue Pharma in Stanford, Connecticut. And Yeah,
- 53:21Speaker 4: the owner of the gallery was named Fernando Luis Alvarez,
- 53:25Speaker 4: and he collaborated with a Boston based artist named Dominique
- 53:28Speaker 4: Esposito to commission this piece, and he has a great
- 53:32Speaker 4: quote here, Ben if you shouldn't mind.
- 53:35Speaker 1: He told Time magazine, the justice department in the country
- 53:38Speaker 1: has to start putting some of these people behind bars
- 53:42Speaker 1: because they go on and make a lot of money
- 53:44Speaker 1: and then they pay a fine and so be it
- 53:46Speaker 1: as just not the way it should be. And he
- 53:50Speaker 1: got charged by the police, I.
- 53:51Speaker 4: Think, yeah, for obstruction of free passage. It wasn't even
- 53:57Speaker 4: in traffic, it was a footpath, and also for infering
- 54:00Speaker 4: with the police after he refused to remove the sculpture,
- 54:03Speaker 4: and it sounds like he's going to be charged, you know,
- 54:06Speaker 4: whatever goes along with those misdemeanor violations, and also the
- 54:09Speaker 4: cost of removing it because it looks like it was
- 54:11Speaker 4: like bolted down to the concrete. So he's probably gonna
- 54:15Speaker 4: have to pay some fees to patch up the sidewalk
- 54:17Speaker 4: where he put it in. And removal of this thing
- 54:20Speaker 4: would be no joke because it's it's about ten and
- 54:22Speaker 4: a half feet long, and they had to, you know,
- 54:25Speaker 4: the city government I guess or law enforcement had to
- 54:29Speaker 4: remove it and also store it. So you know, this
- 54:32Speaker 4: guy's going to get pretty hefty fine for that. Whatever
- 54:34Speaker 4: they assess.
- 54:36Speaker 1: However, we are a pretty resourceful team conspiracy realists. If
- 54:41Speaker 1: you're listening to this, you happen to be in the
- 54:43Speaker 1: area and you practice law, why not accept his payment
- 54:47Speaker 1: that gigantic sculpture, get the guy out of out of court,
- 54:52Speaker 1: and then plant it back. I love there is. We're
- 54:56Speaker 1: going a little bit long on today's episode because, first
- 55:01Speaker 1: because this is incredibly important and it doesn't matter what
- 55:04Speaker 1: your personal beliefs are. The numbers are real and they
- 55:07Speaker 1: have no opinion. There's something else we wanted to mention
- 55:11Speaker 1: that we were talking about with our super producer Paul,
- 55:14Speaker 1: who bought up a great point. This is obviously not
- 55:17Speaker 1: only is it not the first opium crisis in the world,
- 55:20Speaker 1: it's not the first drug crisis in the US. In
- 55:24Speaker 1: the eighties, there was the crack cocaine epidemic, and the
- 55:28Speaker 1: government handled it in a very different way. They didn't
- 55:34Speaker 1: they didn't say, let's sort of soft foot around on
- 55:37Speaker 1: a federal level holding pharmaceutical companies responsible. Right because all
- 55:43Speaker 1: the powerful legislation for this stuff, we should say, is
- 55:45Speaker 1: coming state by state, and we can tell you a
- 55:48Speaker 1: little bit more about that later. But what they did
- 55:51Speaker 1: instead in the War on drugs was add things like
- 55:54Speaker 1: mandatory sentencing, add things like three strike laws for stuff
- 56:00Speaker 1: relatively innocuous like possession, not even with intent to destroy,
- 56:03Speaker 1: for the end user, for the end user, not the supplier,
- 56:08Speaker 1: someone who was addicted to smoking crack is probably not
- 56:15Speaker 1: also pressuring lobbyists right to let the market cocaine more effectively.
- 56:22Speaker 1: So one of the huge differences here that you can
- 56:25Speaker 1: also see in various news articles such as MPRS why
- 56:29Speaker 1: is the opioid epidemic overwhelmingly white? Some of the really
- 56:36Speaker 1: i would say revelatory media research in this thing is
- 56:40Speaker 1: tracing it to the demographic of the end user. Right,
- 56:44Speaker 1: because crack cocaine's user base was portrayed as predominantly people
- 56:49Speaker 1: of color, and the opioid epidemic is portrayed predominantly as
- 56:54Speaker 1: white people.
- 56:56Speaker 2: It's a really I mean, it's an unfortunate point. And
- 56:59Speaker 2: just see you can see how it's shaped the entire
- 57:02Speaker 2: both of the entire processes. One thing we do have
- 57:06Speaker 2: to point out here is that the crack cocaine epidemic
- 57:08Speaker 2: is illegal substance, solely pedaled illegally, right, there's no legal
- 57:15Speaker 2: prescription version of cocaine or crack cocaine now, and in
- 57:19Speaker 2: this case, I think it's kind of the same point
- 57:22Speaker 2: you're making, Ben. In this case, you've got somehow the
- 57:25Speaker 2: same illegal substance change just enough that it can become
- 57:28Speaker 2: a product that can be sold legally.
- 57:31Speaker 4: Yeah, I think they that takeaway here is the money.
- 57:34Speaker 1: Yeah. Well, there's also there's also an interesting thing in
- 57:38Speaker 1: this article that is profoundly disturbing, and it goes back
- 57:42Speaker 1: into stereotypes. Medical professionals have patients based on what they
- 57:49Speaker 1: perceive the patient's identity to be. There's a drug abuse
- 57:54Speaker 1: expert in this interview on NPR named doctor Andrew Koalagny
- 57:57Speaker 1: apologies if I'm mispronouncing your name, doctor, and Colodeney notes
- 58:03Speaker 1: that one thing he's seeing is that doctors tend to
- 58:06Speaker 1: prescribe is a quote here, doctors tend to prescribe narcotics
- 58:11Speaker 1: more cautiously to their non white patients because it seems
- 58:16Speaker 1: that doctors themselves have stereotypes about addiction. So really, yeah,
- 58:22Speaker 1: so that that sort of racially based or motivated attitude
- 58:27Speaker 1: on the part of the medical professional may be playing
- 58:30Speaker 1: a role too.
- 58:32Speaker 2: Geez.
- 58:32Speaker 4: There's an interesting analog or with something that's going on
- 58:35Speaker 4: in the news right now. Matt. You mentioned the difference
- 58:37Speaker 4: between or one of the differences in the way that
- 58:40Speaker 4: the government handled it is the fact that heroin and opiates,
- 58:43Speaker 4: there's a legal version of it that you can be prescribed.
- 58:46Speaker 4: No analog exists for crack cocaine or cocaine what have.
- 58:49Speaker 2: You, since they took it out of cocaine.
- 58:51Speaker 4: So they took you out of coca cola. And you know,
- 58:53Speaker 4: Mommy's little helpers or whatever. Right, And I've talked about
- 58:56Speaker 4: this before, and it's just interesting because it really is
- 58:58Speaker 4: an ongoing story. There is what's what's kind of built
- 59:01Speaker 4: as an herbal supplement called kratom. It's a it's a
- 59:04Speaker 4: crowned up leaf from a tree that's indigenous to like
- 59:08Speaker 4: Malaysia or some somewhere Thailand. That's that's correct, And it
- 59:11Speaker 4: has been on the DEA's watch list for a long
- 59:14Speaker 4: time now because it has supposedly analog analogous sensations and
- 59:19Speaker 4: effects to opioids, and a lot of people take it,
- 59:24Speaker 4: and there's a whole you know, it's it's it's a
- 59:25Speaker 4: billion dollar industry and there's all like an organization that
- 59:29Speaker 4: is like the advocate for this substance, and people say
- 59:32Speaker 4: how they take it to get off of prescription painkillers
- 59:36Speaker 4: or to treat some of the things that prescription pills
- 59:39Speaker 4: would be, you know, prescribed for and what have you.
- 59:41Speaker 4: And then of course there is also a people take
- 59:44Speaker 4: it for anxiety, what have you. But there's also potential
- 59:46Speaker 4: for abuse. But the latest is that the DEA is
- 59:50Speaker 4: finally really cracking down on it, and it looks like
- 59:53Speaker 4: they may make it federally illegal sooner rather than later.
- 59:57Speaker 1: I meaned it, schedule it.
- 59:59Speaker 4: Make it one.
- 1:00:01Speaker 1: Wow.
- 1:00:01Speaker 4: Can you know how many deaths have been attributed to
- 1:00:03Speaker 4: this substance?
- 1:00:04Speaker 1: Roughly zero thirty thirty And.
- 1:00:07Speaker 4: I don't know the details about that, But how many
- 1:00:09Speaker 4: deaths did we say we're attributed to prescription painkillers?
- 1:00:12Speaker 1: Thousands?
- 1:00:13Speaker 4: So why is the attitude so different? Why is this
- 1:00:15Speaker 4: substance on the chopping block, and yet the others that
- 1:00:19Speaker 4: we have massive amounts of data that show it is
- 1:00:22Speaker 4: in fact deadly are not. I think it comes down
- 1:00:26Speaker 4: to Big Pharma is pissed that this legal substance that
- 1:00:31Speaker 4: you can buy in head shops and online or what
- 1:00:33Speaker 4: have you is potentially taking away taking money out of
- 1:00:36Speaker 4: their pocket.
- 1:00:37Speaker 1: Yeah, I want to. I think that's a fantastic point.
- 1:00:41Speaker 1: I want to go back, though, make sure we don't
- 1:00:43Speaker 1: miss the point with what this doctor was saying about
- 1:00:47Speaker 1: the way we handle these epidemics. And I think they
- 1:00:50Speaker 1: tie in because in the doctor Kladney was saying that
- 1:00:57Speaker 1: in this epidemic where we do see these legal analogs,
- 1:01:02Speaker 1: he's saying, we're hearing from policymakers, even conservative politicians, when
- 1:01:07Speaker 1: they talk about the crisis, they begin by saying, we
- 1:01:09Speaker 1: cannot arrest our way out of this. We can see
- 1:01:13Speaker 1: that people who are addicted can access effective treatment. We
- 1:01:16Speaker 1: did not hear that during the crack cocaine epidemic. It's
- 1:01:18Speaker 1: good that we're hearing it now, but it's too bad
- 1:01:20Speaker 1: we didn't hear it then. And if kretom is a
- 1:01:25Speaker 1: possible way to help people in need, then it seems
- 1:01:29Speaker 1: just objectively, it seems pretty counterintuitive to remove that from
- 1:01:33Speaker 1: the conversation.
- 1:01:34Speaker 4: Absolutely, I didn't mean to derail the racial tones to
- 1:01:37Speaker 4: this comparison. I think that is absolutely accurate. I think
- 1:01:41Speaker 4: this is almost It just really goes to show that
- 1:01:43Speaker 4: there is not only that bias in place in this discussion,
- 1:01:48Speaker 4: but also that whole lining of the pockets. Absolutely element
- 1:01:53Speaker 4: I think there is hand in hand.
- 1:01:55Speaker 2: Yeah, well here's the thing. Does cretum then do you
- 1:01:58Speaker 2: get kreatum clinics like method own clinics and are addicted
- 1:02:02Speaker 2: to said there's potential for abuse.
- 1:02:04Speaker 4: That's here's what the DEA has to say about this.
- 1:02:07Speaker 4: One of their big beefs is that it's being supposedly
- 1:02:10Speaker 4: marketed for those things that I mentioned earlier, withdrawal from opiates,
- 1:02:15Speaker 4: treating things that would require a more professional medical opinion,
- 1:02:19Speaker 4: et cetera. Supposedly, they say it's being marketed that way.
- 1:02:22Speaker 4: So it says, quote, the FDA knows people are using
- 1:02:24Speaker 4: Creative to treat conditions like pain, anxiety, and depression, which
- 1:02:27Speaker 4: are serious medical conditions that require proper diagnosis and oversight
- 1:02:30Speaker 4: from a licensed health care provider. We also know that
- 1:02:32Speaker 4: the substance is being actively marketed and distributed for these purposes. Importantly,
- 1:02:36Speaker 4: evidence shows that creative has similar effects to narcotics like
- 1:02:39Speaker 4: opioids and carry similar risks of abuse, addiction, and in
- 1:02:42Speaker 4: some cases death. But then you have people that use
- 1:02:45Speaker 4: it and talk about it very openly that a part
- 1:02:48Speaker 4: of these organizations that say it's just not the same
- 1:02:52Speaker 4: that they were able to use it because as a
- 1:02:54Speaker 4: similar effect to narcotics, but that they it literally allowed
- 1:02:58Speaker 4: them to kind of integrate back into society in a
- 1:03:00Speaker 4: way that is weren't able to do with the narcotics
- 1:03:02Speaker 4: that they were on, the heavy doses of narcotics.
- 1:03:04Speaker 1: So MDMA and PTSD.
- 1:03:08Speaker 2: Yeah, what we need is a prescription version that we
- 1:03:12Speaker 2: can sell for eighty dollars a tablet and then it's
- 1:03:16Speaker 2: good to go.
- 1:03:17Speaker 1: No cures, only treatments, you.
- 1:03:20Speaker 2: Know, I know, we're wrapping up. We're going way too long. Sure,
- 1:03:23Speaker 2: we didn't even really get into the fentanyl thing that's
- 1:03:26Speaker 2: happening right now as part of the crisis. Like the
- 1:03:28Speaker 2: reason why so many people are dying right now today
- 1:03:31Speaker 2: while we're recording this because the heroin supply that is
- 1:03:34Speaker 2: illegal that people are getting rather than the prescription drugs,
- 1:03:38Speaker 2: is laced with this thing that's deadly in very very
- 1:03:41Speaker 2: very small doses.
- 1:03:43Speaker 1: Yeah, can you tell us a little bit about that.
- 1:03:44Speaker 2: Well, it's just a fact fentanyl is a drug that's
- 1:03:48Speaker 2: being laced within supplies of heroin coming into the United States,
- 1:03:52Speaker 2: and it maybe it's a whole different episode for another
- 1:03:56Speaker 2: show where we talk about like why is that happening?
- 1:03:59Speaker 2: Is it just to save cost on the manufacturer's side.
- 1:04:02Speaker 1: How does heroin get into the States?
- 1:04:04Speaker 2: Yes? Well, yeah, and and what is the difference between
- 1:04:09Speaker 2: fentanyl and all this stuff? And who would just who
- 1:04:10Speaker 2: would be putting it in there?
- 1:04:12Speaker 4: There's a there's a photo in this article from statnews
- 1:04:15Speaker 4: dot com. The headline is why fentanyl is deadlier than
- 1:04:17Speaker 4: heroin in a single photo, and it's these two inch
- 1:04:21Speaker 4: tall vials. On the left is heroin and it has
- 1:04:25Speaker 4: about a centimeter of powder in the bottom of it,
- 1:04:28Speaker 4: and then the next to it is fentanyl. And it
- 1:04:30Speaker 4: just looks like residue, Like there's like maybe ten grains
- 1:04:34Speaker 4: that you can see. Wow, it looks like the leftovers
- 1:04:36Speaker 4: in like a salt shaker.
- 1:04:38Speaker 1: And that's an equivalent dose.
- 1:04:39Speaker 2: Yeah, oh my god, Yeah, terrified. That's terrified.
- 1:04:43Speaker 1: So maybe that is a future episode for us. Today,
- 1:04:47Speaker 1: we want to thank you for thank you for taking
- 1:04:50Speaker 1: this strange journey with us. It's only the beginning of
- 1:04:55Speaker 1: something that has been ongoing for you know, not just
- 1:04:59Speaker 1: since maybe since the nineteen nineties here in the States,
- 1:05:02Speaker 1: but ongoing for thousands of years in terms of our
- 1:05:07Speaker 1: species struggle with opium So, in short answer for today's question, yes,
- 1:05:14Speaker 1: the opium epidemic in the US is at least partially
- 1:05:17Speaker 1: the result of an active and very successful conspiracy on
- 1:05:21Speaker 1: the part of pharmaceutical companies, some of them, not all
- 1:05:24Speaker 1: of them, to twist the law or circumvent it entirely
- 1:05:27Speaker 1: and push these painkillers on innocent patience. To biggest factors
- 1:05:31Speaker 1: in this are private partnerships with politicians, with holding or
- 1:05:35Speaker 1: suppressing of important information, and nowadays twenty eighteen, multiple companies
- 1:05:41Speaker 1: claim they are in fact combating the crisis they or
- 1:05:45Speaker 1: companies like them, did play a role in creating. None
- 1:05:48Speaker 1: of these companies to date have acknowledged that they played
- 1:05:51Speaker 1: this role, even when internal memos show that they consciously
- 1:05:55Speaker 1: did so. It's pretty easy to see how critics don't
- 1:05:58Speaker 1: trust these statements. Currently, the attorney's general of forty one
- 1:06:03Speaker 1: different US states, inspired by aggressive legislation from Ohio, are
- 1:06:07Speaker 1: joining forces to investigate these companies. The ultimate goal of
- 1:06:11Speaker 1: these lawsuits is to force the manufacturers to change their
- 1:06:14Speaker 1: marketing tactics offer better warnings as to how addictive these
- 1:06:18Speaker 1: things can be. So far, all of these cases have
- 1:06:22Speaker 1: been civil and not criminal, and gosh, we have war
- 1:06:27Speaker 1: as a final As a final word, we want to
- 1:06:29Speaker 1: hear from you. What are the consequences for these companies,
- 1:06:32Speaker 1: What should they be? How can societies and grips of
- 1:06:36Speaker 1: these epidemics hope to combat them. The answers have a
- 1:06:40Speaker 1: wide range of approach and plausibility, but one thing is
- 1:06:43Speaker 1: for sure. At the rate people are overdosing here, at
- 1:06:46Speaker 1: least in our neck of the global woods, are projected
- 1:06:49Speaker 1: five hundred thousand Americans could dive from opioid misuse in
- 1:06:52Speaker 1: the next ten years. If you are one of the
- 1:06:56Speaker 1: millions of Americans struggling within an addiction to opioid drugs,
- 1:07:00Speaker 1: please reach out directly to one of the many free
- 1:07:03Speaker 1: treatment centers in your area. There are numbers you can call.
- 1:07:07Speaker 1: We guarantee you are worth it, and your time is
- 1:07:10Speaker 1: worth it. The time of your loved ones is worth
- 1:07:13Speaker 1: it as well. We'd also like to hear your story,
- 1:07:16Speaker 1: and we promise we won't share it unless you give
- 1:07:18Speaker 1: us the oka to do so.
- 1:07:20Speaker 2: And that's the end of this classic episode. If you
- 1:07:23Speaker 2: have any thoughts or questions about this episode, you can
- 1:07:27Speaker 2: get into contact with us in a number of different ways.
- 1:07:30Speaker 2: One of the best is to give us a call.
- 1:07:31Speaker 2: Our number is one eight three three STDWYTK. If you
- 1:07:36Speaker 2: don't want to do that, you can send us a
- 1:07:38Speaker 2: good old fashioned email.
- 1:07:40Speaker 1: We are conspiracy at iHeartRadio dot com.
- 1:07:44Speaker 2: Stuff they don't want you to know. Is a production
- 1:07:46Speaker 2: of iHeartRadio. For more podcasts from iHeartRadio, visit the iHeartRadio app,
- 1:07:51Speaker 2: Apple Podcasts, or wherever you listen to your favorite shows.